Imaging of lesions in a murine rheumatoid arthritis model with a humanized anti-interleukin-6 receptor antibody
暂无分享,去创建一个
Kanji Sugimoto | T. Nishimura | T. Kishimoto | K. Yoshizaki | N. Nishimoto | Tsunehiko Nishimura | Tadamitsu Kishimoto | Kazuyuki Yoshizaki | K. Sugimoto | Norihiro Nishimoto
[1] J. Dayer,et al. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. , 1995, Arthritis and rheumatism.
[2] T. Hirano,et al. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[3] F. Houssiau,et al. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. , 1988, Arthritis and rheumatism.
[4] H. Matsuno,et al. Treatment of rheumatoid synovitis with anti-reshaping human interleukin-6 receptor monoclonal antibody: use of rheumatoid arthritis tissue implants in the SCID mouse model. , 1998, Arthritis and rheumatism.
[5] T. Hirano,et al. In vivo effects of recombinant human interleukin-6 in primates: stimulated production of platelets. , 1990, Blood.
[6] 田賀 哲也. Receptors for B cell stimulatory factor 2 : quantitation, specificity, distribution, and regulation of their expression , 1988 .
[7] M. Abrams,et al. [99mTc]tricine: a useful precursor complex for the radiolabeling of hydrazinonicotinate protein conjugates. , 1995, Bioconjugate chemistry.
[8] N. Udagawa,et al. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[9] T. Kishimoto,et al. The biology of interleukin-6. , 1989, Blood.
[10] J. Saldanha,et al. Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth. , 1993, Cancer research.
[11] A. Fischman,et al. Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[12] L. Aarden,et al. Interleukin-6 (IL-6) in synovial fluid and serum of patients with rheumatic diseases. , 1988, Scandinavian journal of rheumatology.
[13] T. Kishimoto,et al. Anti-interleukin 6 receptor antibody treatment in rheumatic disease , 2000, Annals of the rheumatic diseases.
[14] T. Kishimoto,et al. Therapy of rheumatoid arthritis by blocking IL-6 signal transduction with a humanized anti-IL-6 receptor antibody , 2004, Springer Seminars in Immunopathology.
[15] J. Dayer,et al. Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritis , 1995 .
[16] S. Clark,et al. B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes. , 1988, Journal of immunology.